Altogether, these findings strongly suggest that CD39 contributes to the regulation of the inflammatory microenvironment, and that changes in CD39 expression or function might promote the onset and perpetuation of IBD. The gene discussed is ENTPD1; the disease is inflammatory bowel disease.